Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

VC-funded Company:

Day One Biopharmaceuticals
395 Oyster Point Blvd, Suite 217
South San Francisco, CA 94080
Phone: 650-484-0899
https://dayonebio.net/

Inspired by children with cancer, Day One Biopharmaceuticals creatively and intentionally develops promising new therapies that change the outcome for people of all ages living with cancer. Day One's first announced program is DAY101, an oral, once-a-week, type II pan-RAF inhibitor that is currently being evaluated in human clinical trials. Day One partners with leading clinical oncologists, families, and scientists to identify, acquire, and develop emerging cancer treatments that can help both children and adults living with cancer. Through Day One and its collaborators, cancer drug development comes of age.

Key Contact
Name
Julie Grant
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
05/21/20 $60,000,000 Series A Access Industries
Atlas Venture
Canaan Partners